Immuneed

Immuneed

Forskning

Select the most promising drug candidates with us and accelerate your path to drug development.

Om oss

Our technology, ID.Flow, utilizes freshly donated human blood to help researchers better understand drug-induced immune reactions during non-clinical development. By improving the accuracy and relevance of safety and efficacy assessments, we reduce the need for animal studies and enhance the translatability of preclinical findings.

Bransch
Forskning
Företagsstorlek
11–50 anställda
Huvudkontor
Uppsala
Typ
Privatägt företag
Grundat
2014
Specialistområden
Immunotoxicity, Drug development, Monoclonal antibodies, Immune complexes, Contract research organization, Cytokine Release Assay, Safety Assessment, MoA, Functional studies, Biologics, Proteins, Peptides, Small molecules, Complement Activation, Innate Immunity, In-Vitro Immunotoxicity, Immune profiling, Immuno-oncology, Platelet activation, Monocyte activation, ADCC & CDC assays och non-clinical

Adresser

Anställda på Immuneed

Uppdateringar

Liknande sidor

Finansiering

Immuneed 1 runda totalt

Senaste finansieringsrunda

Kapital

504 292,00 US$

Investerare

Almi Invest
Se mer info på crunchbase